BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2005
View Archived Issues
Nalfurafine hydrochloride reduces scratching in a possible murine model of pruritis
Read More
Recent patents cover novel treatments for neurodegenerative disorders
Read More
New treatments for psychosis and depression in early development
Read More
Novel diagnostic agents disclosed by Amersham
Read More
MMP inhibitors for arthritis emerge from Japan Tobacco R&D
Read More
CYC-10268 targets macrophage survival in vitro
Read More
ELB-353: in vitro and in vivo data demonstrate potential for asthma/COPD
Read More
MEK1 inhibitor achieves superior results in a murine colon cancer model
Read More
TTI-237: A novel, small-molecule tubulin inhibitor with novel mechanism of action
Read More
Mycophenolate mofetil shows promise in the treatment of inflammatory eye disease
Read More
Gentium updates status of defibrotide program
Read More
Enrollment completed in phase II study of MN-001 for asthma
Read More
Phase III Veronate trial recommended to continue by DSMB
Read More
Novartis and Alnylam establish major RNAi alliance
Read More
Avax files IND for phase I/II NSCLC study of AC Vaccine Therapeutic
Read More
ACTIVE W arm discontinued in clopidogrel program
Read More
Centocor selects new target in Morphosys collaboration
Read More
huN901-DM1 enters clinical testing for multiple myeloma
Read More
Celera Diagnostics and Merck & Co extend Alzheimer's collaboration
Read More
Genentech targets Lucentis BLA filing for December
Read More
WHO urges monitoring of antimalarials for effectiveness
Read More
Ataciguat - a promising therapeutic option for cardiovascular complications in diabetic patients
Read More
In vivo models validate superior efficacy of BAY-59-7939 over fondaparinux
Read More
AVE-0118 is safe in experimental CHF
Read More
Novel pathway-selective LXR modulator developed
Read More
Novel HCV-NS3 protease inhibitor enters clinical development
Read More
Preclinical studies evaluate the antinociceptive effects of TQ-1015
Read More
Dronedarone reduces the ventricular rate of patients with atrial fibrillation
Read More
AZD-6140 shows efficacy in inhibiting platelet aggregation in patients with atherosclerosis
Read More
Swiss approval for once-monthly Bonviva
Read More